Terence J Scallen

Title: Terence J Scallen: Innovator in Pharmaceutical Chemistry

Introduction

Terence J Scallen is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of serious diseases. With a total of 11 patents to his name, Scallen's work has the potential to impact the lives of many individuals suffering from debilitating conditions.

Latest Patents

One of Scallen's latest patents focuses on rosuvastatin enantiomer compounds. This invention discloses a method for treating diseases characterized by diminished or aberrant cellular function, including AIDS, cancer, and Alzheimer's Disease. The method involves administering a therapeutically effective amount of rosuvastatin enantiomer compounds in their (3R, 5R), (3S, 5R), or (3S, 5S) configurations, or pharmaceutically acceptable salts thereof. Additionally, biologically-active rosuvastatin enantiomer compounds with (3R, 5R), (3S, 5R), and (3S, 5S) stereochemistry are also disclosed.

Career Highlights

Throughout his career, Scallen has worked with esteemed institutions, including the University of New Mexico. His research and innovations have contributed to advancements in medical treatments and pharmaceutical applications.

Collaborations

Some of his notable coworkers include Galen D Knight and Paul L Mann. Their collaborative efforts have further enhanced the impact of Scallen's inventions in the field.

Conclusion

Terence J Scallen's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving healthcare. His work continues to pave the way for new treatments that could benefit countless individuals.